Mode of action of antituberculous drugs and mechanisms of drug resistance in Mycobacterium tuberculosis.
Rastogi
N
N
Unité de la Tuberculose et des Mycobactéries, Institut Pasteur, Paris.
David
H L
HL
D000904:Antibiotics, Antitubercular / Q000494:pharmacology; D003523:Cycloserine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D004352:Drug Resistance, Microbial; D004977:Ethambutol / Q000494:pharmacology*; D006801:Humans; D066298:In Vitro Techniques; D007538:Isoniazid / Q000494:pharmacology*; D009169:Mycobacterium tuberculosis / Q000187:drug effects*; D012293:Rifampin / Q000494:pharmacology*
D000904:Antibiotics, Antitubercular; D004977:Ethambutol; D003523:Cycloserine; D007538:Isoniazid; D012293:Rifampin